NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020)
NovaBridge Biosciences (NBP) posted quarterly Long-Term Debt Repayments of $15.1 million for Q4 2020, down 33.53% year-on-year from $22.7 million in Q1 2020, and down 33.53% on a QoQ basis from $22.7 million in Q4 2019.
NovaBridge Biosciences (NBP) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Long-Term Debt Repayments for 2 consecutive years, with $15.1 million the latest figure, recorded in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.64 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2020 | 15.09 Mn |
| Dec 31, 2019 | 22.70 Mn |
| Dec 31, 2019 | 22.70 Mn |